PH16250A - Pharmaceutical composition of therapeutic value in the treatment of some shock conditions - Google Patents

Pharmaceutical composition of therapeutic value in the treatment of some shock conditions

Info

Publication number
PH16250A
PH16250A PH24981A PH24981A PH16250A PH 16250 A PH16250 A PH 16250A PH 24981 A PH24981 A PH 24981A PH 24981 A PH24981 A PH 24981A PH 16250 A PH16250 A PH 16250A
Authority
PH
Philippines
Prior art keywords
treatment
pharmaceutical composition
therapeutic value
shock conditions
shock
Prior art date
Application number
PH24981A
Other languages
English (en)
Inventor
Giancarlo Sportoletti
Alessandro Baglioni
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of PH16250A publication Critical patent/PH16250A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH24981A 1979-12-28 1980-12-15 Pharmaceutical composition of therapeutic value in the treatment of some shock conditions PH16250A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT28416/79A IT1127321B (it) 1979-12-28 1979-12-28 Composizione farmaceutiche aventi specifiche proprieta' terapeutiche nei confronti dell'edema polmonare acuto,di alcuni stati di shock e dell'iperfibrinolisi

Publications (1)

Publication Number Publication Date
PH16250A true PH16250A (en) 1983-08-16

Family

ID=11223557

Family Applications (1)

Application Number Title Priority Date Filing Date
PH24981A PH16250A (en) 1979-12-28 1980-12-15 Pharmaceutical composition of therapeutic value in the treatment of some shock conditions

Country Status (24)

Country Link
US (2) US4308280A (fr)
JP (1) JPS56100717A (fr)
AR (1) AR227297A1 (fr)
AU (1) AU529650B2 (fr)
BE (1) BE886759A (fr)
BR (1) BR8008492A (fr)
CA (1) CA1166160A (fr)
DE (1) DE3027056A1 (fr)
DK (1) DK523980A (fr)
ES (1) ES8205394A1 (fr)
FI (1) FI803995L (fr)
FR (1) FR2472387A1 (fr)
GB (1) GB2066073B (fr)
GR (1) GR72834B (fr)
IE (1) IE50550B1 (fr)
IN (1) IN151731B (fr)
IT (1) IT1127321B (fr)
LU (1) LU83028A1 (fr)
NL (1) NL8006706A (fr)
NO (1) NO803918L (fr)
PH (1) PH16250A (fr)
PT (1) PT72273B (fr)
SE (1) SE8009102L (fr)
ZA (1) ZA807514B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112805A (en) * 1985-11-22 1992-05-12 Labsystems, Oy Pharmaceutical preparation for promoting epithelial healing and prevention of epithelial destruction
IT1201511B (it) * 1985-12-23 1989-02-02 Italfarmaco Spa Derivati citoprotettivi in patologie a base ischemica,loro preparazione e composizioni che li cntengono
GB8929076D0 (en) * 1989-12-22 1990-02-28 Scras Treatment of shock by blocking agents of edrf effect or formation
SE468881B (sv) * 1991-01-09 1993-04-05 Kabi Pharmacia Ab Anvaendning av vissa foereningar foer framstaellning av laekemedel foer behandling av endotoxininducerade effekter samt saett att avlaegsna endotoxiner ur diverse loesningar
US5436270A (en) * 1993-04-07 1995-07-25 National Science Council Method for protecting against endotoxin-induced shock
US6613358B2 (en) 1998-03-18 2003-09-02 Theodore W. Randolph Sustained-release composition including amorphous polymer
US20050148669A1 (en) * 2004-10-21 2005-07-07 Daniel Amato Amino acid esters as nutrient supplements and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB897439A (en) * 1959-05-08 1962-05-30 American Cyanamid Co Compositions for intravenous use for blood clot lysis
JPS514125A (en) * 1974-06-27 1976-01-14 Mitsubishi Chem Ind N22 ashiru ll arugininesuterumatahasono sanfukaenno seizoho

Also Published As

Publication number Publication date
IE802606L (en) 1981-06-28
AU529650B2 (en) 1983-06-16
FI803995L (fi) 1981-06-29
ZA807514B (en) 1981-11-25
FR2472387A1 (fr) 1981-07-03
JPS56100717A (en) 1981-08-12
FR2472387B1 (fr) 1983-10-07
JPS6342603B2 (fr) 1988-08-24
BR8008492A (pt) 1981-07-14
IN151731B (fr) 1983-07-16
GB2066073B (en) 1984-02-01
PT72273A (en) 1981-01-01
NO803918L (no) 1981-06-29
PT72273B (en) 1981-11-05
LU83028A1 (de) 1981-03-27
SE8009102L (sv) 1981-06-29
US4308280A (en) 1981-12-29
US4405643A (en) 1983-09-20
DK523980A (da) 1981-06-29
ES497509A0 (es) 1982-06-16
GB2066073A (en) 1981-07-08
IT7928416A0 (it) 1979-12-28
BE886759A (nl) 1981-04-16
AR227297A1 (es) 1982-10-15
IT1127321B (it) 1986-05-21
ES8205394A1 (es) 1982-06-16
DE3027056A1 (de) 1981-07-02
GR72834B (fr) 1983-12-07
AU6502880A (en) 1981-07-02
NL8006706A (nl) 1981-07-16
IE50550B1 (en) 1986-05-14
CA1166160A (fr) 1984-04-24

Similar Documents

Publication Publication Date Title
ZA804180B (en) Medicaments for the treatment of disorders in lipometabolism and their use
JPS5692816A (en) Prescription of long controlled effect belnded medicine and its composition
JPS565413A (en) Continuously releasing therapeutic composition
GB2103591B (en) Pharmaceutical compositions and process
JPS5643217A (en) Water drug for external application for trauma treatment and manufacture thereof
ZA791728B (en) Cerebral therapeutic agent and its use
JPS55100313A (en) Drug composition and its manufacture
HU178841B (en) Cattle-leader for the prophylactic or therapeutic treatment of cattle
GB2057872B (en) Use of glycerylphosphoryl derivatives in the therapy of dislipaemia hepatitis and like pathological conditions and pharmaceutical compositions therefor
GB2071091B (en) Acyl-derivatives of carnitine and the therapeutic use thereof
PH16250A (en) Pharmaceutical composition of therapeutic value in the treatment of some shock conditions
JPS55154973A (en) 1*3*77trialkylxanthine* its manufacture and medical composition
JPS55149272A (en) Novel 5hhfuranonee2 and 3hhdihydrofuranonee2 derivative* their manufacture and use as medicine
GB2022998B (en) Phermaceutical composition for the treatment of neoplasticand other diseases
JPS5626890A (en) Halovincamone derivatives* thei manufacture and medicinal composition containing it
IL49122A (en) L-pyroglutamyl-l-histidyl-3-alkyl-prolineamide processes for their preparation and therapeutic compositions containing the same
DE3272384D1 (en) Medicinal composition for the treatment of certain neuroviroses
JPS552698A (en) Thienooor furopyridone derivative* its manufacture and therapeutic composition containing it
EG14024A (en) Pharmaceutical compositions and their use in the profyloxis and or treatment of certain diseases
JPS5495595A (en) Thienoopyridine derivative* its manufacture and therapeutic composition containing it as active component
JPS55136260A (en) Phenylethylamine derivative*its manufacture and its medical composition
GB2057874B (en) Compositions containing azo compounds and use thereof for therapeutic treatment
JPS5533487A (en) Medical composition and its prescription
JPS5699472A (en) 11aminoopropanee22ol derivative* its manufacture and therapeutical composition
GB2077265B (en) N-trifluoroacetyladriamycin-14-o-hemiglutarate and hemiadipate and therapeutic compositions containing the same